Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
MSCI
MSCI
$40.9B
| $81M | 0.11% |
140,521
+75,300
| +115% | +$41.7M |
2025 Q1
1 quarter
|
|
202
Peabody Energy
BTU
$3.05B
| $81M | 0.11% |
6,034,990
+636,900
| +12% | +$8.41M |
2017 Q3
31 quarters
|
|
203
Occidental Petroleum
OXY
$60.2B
| $80.9M | 0.11% |
1,925,393
+815,544
| +73% | +$34.1M |
2024 Q3
3 quarters
|
|
204
RELX
RELX
$61.2B
| $80.8M | 0.11% |
1,486,400
+163,700
| +12% | +$8.66M |
2014 Q3
43 quarters
|
|
205
Haleon
HLN
$40.6B
| $80.7M | 0.11% |
7,786,699
+6,547,000
| +528% | +$69.1M |
2022 Q3
11 quarters
|
|
206
Devon Energy
DVN
$53.9B
| $80.5M | 0.11% |
2,529,730
+1,500,300
| +146% | +$47.8M |
2023 Q3
7 quarters
|
|
207
Teradyne
TER
$61.4B
| $80.1M | 0.11% |
891,100
+425,439
| +91% | +$34M |
2024 Q4
2 quarters
|
|
208
Dollar General
DG
$27.6B
| $80M | 0.11% |
699,700
+682,800
| +4,040% | +$67.8M |
2024 Q2
4 quarters
|
|
209
On Holding
ONON
$11.4B
| $80M | 0.11% |
1,536,400
+943,500
| +159% | +$48.1M |
2025 Q1
1 quarter
|
|
210
Target
TGT
$70.8B
| $79.4M | 0.11% |
805,300
-10,700
| -1% | -$1.03M |
2025 Q1
1 quarter
|
|
|
HOLX
211
DELISTED
Hologic
HOLX
| $79.1M | 0.11% |
1,213,313
-618,218
| -34% | -$37.1M |
2020 Q3
19 quarters
|
|
212
Mercury Insurance
MCY
$5.69B
| $78.9M | 0.11% |
1,172,082
-115,597
| -9% | -$6.88M |
2015 Q3
39 quarters
|
|
213
Futu Holdings
FUTU
$15.2B
| $78.4M | 0.1% |
634,226
+513,100
| +424% | +$52.5M |
2022 Q2
12 quarters
|
|
214
Pinduoduo
PDD
$112B
| $77.7M | 0.1% |
742,000
+152,100
| +26% | +$16M |
2024 Q2
4 quarters
|
|
215
Toronto Dominion Bank
TD
$186B
| $77.6M | 0.1% |
1,056,680
+501,300
| +90% | +$32.7M |
2024 Q3
3 quarters
|
|
216
Maplebear
CART
$11B
| $77.6M | 0.1% |
1,714,253
+254,200
| +17% | +$11.1M |
2024 Q2
4 quarters
|
|
217
Amgen
AMGN
$220B
| $77.4M | 0.1% |
277,300
+162,900
| +142% | +$46.1M |
2024 Q4
2 quarters
|
|
218
TransDigm Group
TDG
$60.4B
| $76.8M | 0.1% |
50,500
-19,500
| -28% | -$27.4M |
2022 Q1
13 quarters
|
|
219
Janus Henderson AAA CLO ETF
JAAA
$31.6B
| $76.7M | 0.1% |
1,511,413
-264,487
| -15% | -$13.4M |
2022 Q4
10 quarters
|
|
220
Marqeta
MQ
$1.81B
| $76.3M | 0.1% |
3,272,097
+335,950
| +11% | +$6.38M |
2022 Q1
13 quarters
|
|
221
Cigna
CI
$74.1B
| $76.1M | 0.1% |
230,259
+223,159
| +3,143% | +$71.9M |
2025 Q1
1 quarter
|
|
222
Ralph Lauren
RL
$21.8B
| $75.8M | 0.1% |
276,400
+12,600
| +5% | +$3.12M |
2023 Q4
6 quarters
|
|
223
IDT Corp
IDT
$2.02B
| $75.1M | 0.1% |
1,099,839
-12,167
| -1% | -$697K |
2013 Q2
48 quarters
|
|
224
Brady Corp
BRC
$3.96B
| $74.7M | 0.1% |
1,098,840
+23,100
| +2% | +$1.61M |
2014 Q3
43 quarters
|
|
225
Yum! Brands
YUM
$39.1B
| $74.6M | 0.1% |
503,600
+501,500
| +23,881% | +$73.2M |
2025 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.